Cleared Traditional

K062531 - ANGIOGUARD XP EMBOLI CAPTURE GUIDEWIRE ...

K062531 is an FDA 510(k) clearance for ANGIOGUARD XP EMBOLI CAPTURE GUIDEWIRE ..., manufactured by Cordis Corp., A Johnson & Johnson Co.. The device is a Class 2 Cardiovascular device with product code NTE cleared through the Traditional 510(k) pathway after a 24-day FDA review.

K062531 · Cordis Corp., A Johnson & Johnson Co. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2006
Decision
24d
Days
Class 2
Risk

K062531 is an FDA 510(k) clearance for the ANGIOGUARD XP EMBOLI CAPTURE GUIDEWIRE AND ANGIOGUARD RX EMBOLI CAPTURE GUIDE.... Classified as Temporary Carotid Catheter For Embolic Capture (product code NTE), Class II - Special Controls.

Submitted by Cordis Corp., A Johnson & Johnson Co. (Warren, US). The FDA issued a Cleared decision on September 22, 2006 after a review of 24 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cordis Corp., A Johnson & Johnson Co. devices

FDA 510(k) Submission Details - K062531

510(k) Number K062531 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2006
Decision Date September 22, 2006
Days to Decision 24 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
101d faster than avg
Panel avg: 125d · This submission: 24d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

NTE Device Classification - Class 2, Special Controls

Product Code NTE Temporary Carotid Catheter For Embolic Capture
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
Definition This Device Is A Single Use Percutaneous Catheter System That Is Introduced Into An Artery Through The Skin Using A Guidewire. The Catheter Has An Embolic Capture Filter Or An Occlusion Balloon At The Distal End. The Filter Or Balloon Can Be Placed Either Distally To The Lesion Or Proximally Depending On The Design Of The Device And Intended Use. The Filter Or Balloon Is Used To Capture Embolic Material In A Manner That May Protect Or Prevent A Stroke Or Other Cerebral Vascular Sequelae. The Embolic Capture Device Is Indicated For Use As A Guidewire And Embolic Protection System To Contain And Remove Embolic Material (thrombus/debris) While Performing Angioplasty And Stenting Procedures I
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - NTE Temporary Carotid Catheter For Embolic Capture

All 23
Devices cleared under the same product code (NTE) and FDA review panel - the closest regulatory comparables to K062531.
GUARDWIRE TEMPORARY OCCLUSION AND ASPIRATION SYSTEM- CAROTID
K072990 · Medtronic, Inc. · Oct 2007
FILTERWIRE EZ EMBOLIC PROTECTION SYSTEM (3.5 MM TO 5.5 MM)
K063313 · Boston Scientific Corp · Dec 2006
SPIDERFX EMBOLIC PROTECTION DEVICE
K063204 · Ev3, Inc. · Nov 2006
SPIDERX EMBOLIC PROTECTION DEVICE
K052659 · Ev3, Inc. · Feb 2006
RX ACCUNET 2 EMBOLIC PROTECTION SYSTEM
K042908 · Guidant Corp. · Nov 2004
ACCUNET EMBOLIC PROTECTION SYSTEM, RX ACCUNET EMBOLIC PROTECTION SYSTEM
K042218 · Guidant Corp. · Aug 2004